echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > JCEM: Increasing incidence of benign and malignant tumors in patients with acromegaly

    JCEM: Increasing incidence of benign and malignant tumors in patients with acromegaly

    • Last Update: 2021-08-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Whether patients with acromegaly have an increased risk of cancer remains controversial
    .


    In addition, the risk of benign tumors in these patients has rarely been studied



    Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases.


    This nationwide population-based study aims to investigate the incidence of benign and malignant tumors in patients with acromegaly




     
    The study included 1296 patients (52% were women)
    .


    The average (SD) age at diagnosis was 51.
    6 (14.
    7) years



    Original source:

    Daniela Esposito.


    et al.
    Incidence of Benign and Malignant Tumors in Patients with Acromegaly is Increased: a Nationwide Population-Based Study .
    JCEM.
    2021.
    https://doi.


    Incidence of Benign and Malignant Tumors in Patients with Acromegaly is Increased: a Nationwide Population-Based Study in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.